Where does Nanomedical Diagnostics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nanomedical Diagnostics, Inc. ranks #32,582 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nanomedical Diagnostics, Inc. hold?

Nanomedical Diagnostics, Inc. holds 8 US utility patents granted between 2017 and 2021, spanning 8 technology areas.

What is Nanomedical Diagnostics, Inc.'s Innovation Score?

Nanomedical Diagnostics, Inc. has an Innovation Score of 26.0 out of 100 (19th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Nanomedical Diagnostics, Inc.'s patent grant rate increasing or decreasing?

Nanomedical Diagnostics, Inc.'s recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nanomedical Diagnostics, Inc.'s patents?

Nanomedical Diagnostics, Inc.'s patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nanomedical Diagnostics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nanomedical Diagnostics, Inc.

Q: What technology areas does Nanomedical Diagnostics, Inc. focus on?

Nanomedical Diagnostics, Inc.'s top technology area is H10D (Inorganic Electric Semiconductor Devices) with 5 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H10D (Inorganic Electric Semiconductor Devices).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nanomedical ranks #32,582 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#32,582
of 49,997 US assignees by volume: 19th percentile
by Innovation Score (26.0/100): 14.0
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32582 · US Corporation #32,582 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,582/49,997
PHOTO-FINISH Nacuity Pharmaceutic…
CPC-NARROW H10D · 8 areas
INNOV-THIN 26.0/100
CLAIMS-RICH 14.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nacuity Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bonsai AI · near

26
Diversified… · near

26
Nanomedical… · this assignee

26
Trojan Leisure… · near

26
Doug Carson &… · near

26
3D Lighting… · lowest

7

What this shows Nanomedical's Innovation Score is 26.0/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nanomedical's grants concentrate

Nanomedical Diagnostics, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 62.5% of grants classified under H10D (Inorganic Electric Semiconductor Devices). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2019. By volume, Nanomedical sits between Nacuity Pharmaceuticals, Inc. and National Instruments Ireland Resources Limited.

Nacuity Pharmaceu…

8
Nano 2 0 Business…

8
Nano Composite Pr…

8
Nano-master

8
Nanostone Water

8
Nanotech Security

8
Nanovis

8
National Instrume…

8
Nanomedical Diagn… ◀

8

What this shows Nanomedical holds 8 patents at rank #32,643, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nanomedical

By rank, the assignees closest to #32,643 in granted patent volume.

Leaders in H10D (Inorganic Electric Semiconductor Devices)

Other assignees with the most granted patents in Nanomedical's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nanomedical, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (26 here).

Bonsai AI, Inc. 26 Diversified Innovations Fund, Lllp 26 Trojan Leisure Products, LLC 26 Doug Carson & Associates, Inc. 26

Nanomedical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 19th percentile higher than 19% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Nanomedical Diagnostics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	25.0%
2019	1	12.5%
2020	4	50.0%
2021	1	12.5%

Which technologies does Nanomedical Diagnostics, Inc. patent most?

H10D - Inorganic Electric Semiconductor Devices 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

H01L - Semiconductor Devices NOT Covered BY Class H10 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#32,582

of 49,997 tracked assignees

Innovation Score

26.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nanomedical Diagnostics, Inc.'s patent record in context - here's where to go next.

Nanomedical Diagnostics, Inc.'s lead technology class is H10D (Inorganic Electric Semiconductor Devices), 62.5% of its portfolio - see every assignee active in that class. Explore H10D
Ranked #32,582 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nanomedical Diagnostics, Inc. against Nacuity Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.